Literature DB >> 12107783

Multiple perforated ulcers of the small intestine associated with allergic granulomatous angiitis: report of a case.

Yasuko Nakamura1, Yoichi Sakurai, Toshiki Matsubara, Tomohito Nagai, Shusaku Fukaya, Hiroki Imazu, Shigeru Hasegawa, Masahiro Ochiai, Takahiko Funabiki, Yoshikazu Mizoguchi, Makoto Kuroda.   

Abstract

Although allergic granulomatous angiitis (AGA) is occasionally associated with gastrointestinal lesions, multiple perforated ulcers of the gastrointestinal tract are uncommon. We report herein a case of AGA associated with multiple perforated ulcers that erupted in the small intestine during corticosteroid therapy. A 31-year-old Japanese man was admitted to our hospital with epigastralgia, edema of the bilateral lower extremities, and general malaise. He had a persistent high fever, abdominal pain, and watery diarrhea. Laboratory data showed remarkable eosinophilia. The abdominal pain became exacerbated after the administration of oral prednisolone. Physical examination indicated positive signs of peritoneal irritation in the entire abdomen, and abdominal computed tomography scanning showed intra-abdominal free air, suggesting generalized peritonitis due to intestinal perforation. Laparotomy revealed multiple perforated ulcers in the jejunum and ileum. Histological examination indicated remarkable eosinophilic infiltration in the surrounding area of the small arteries and arterioles located in the submucosal layer, which was compatible with AGA. Although the association of intestinal perforation with AGA is relatively infrequent, intensive perioperative management is essential to ensure a favorable clinical outcome, particularly during the period on corticosteroid therapy.

Entities:  

Mesh:

Year:  2002        PMID: 12107783     DOI: 10.1007/s005950200094

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  7 in total

1.  Double-balloon endoscopy-diagnosed multiple small intestinal ulcers in a Churg-Strauss syndrome patient.

Authors:  Takayoshi Suzuki; Masashi Matsushima; Yoshitaka Arase; Mia Fujisawa; Ichiro Okita; Muneki Igarashi; Jun Koike; Tetsuya Mine
Journal:  World J Gastrointest Endosc       Date:  2012-05-16

Review 2.  Gastrointestinal eosinophils in health, disease and functional disorders.

Authors:  Nicholas Powell; Marjorie M Walker; Nicholas J Talley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-02-02       Impact factor: 46.802

3.  Repressed ileal artery aneurysms in Churg-Strauss syndrome following combination treatment with glucocorticoid and cyclophosphamide.

Authors:  Akira Yamasaki; Katsuyuki Tomita; Yoshihiro Fujii; Yasuyuki Hasegawa; Masanari Watanabe; Hiroyuki Sano; Ryota Okazaki; Yasufumi Ouchi; Seiichi Nakamura; Eiji Shimizu
Journal:  Rheumatol Int       Date:  2008-08-08       Impact factor: 2.631

4.  An aggressive and lethal course of Churg-Strauss syndrome with alveolar hemorrhage, intestinal perforation, cardiac failure and peripheral neuropathy.

Authors:  Aydin Çiledağ; Hülya Deniz; Serpil Eledağ; Canan Özkal; Nurşen Düzgün; Selim Erekul; Demet Karnak
Journal:  Rheumatol Int       Date:  2009-12-19       Impact factor: 3.580

5.  Gastrointestinal perforation due to vasculitis at primary diagnosis of eosinophilic granulomatosis with polyangiitis (EGPA) despite a high dose glucocorticosteroids treatment.

Authors:  Gunter Assmann; Marc Molinger; Michael Pfreundschuh; Rainer Bohle; Vincent Zimmer
Journal:  Springerplus       Date:  2014-08-04

6.  Multiple perforations and fistula formation following corticosteroid administration: A case report.

Authors:  Jing-Ni He; Zhong Tian; Xu Yao; Hang-Yu Li; Yun Yu; Yuan Liu; Jin-Gang Liu
Journal:  World J Clin Cases       Date:  2017-02-16       Impact factor: 1.337

Review 7.  Cryptogenic multifocal ulcerous stenosing enteritis: a review of the literature.

Authors:  Darina Kohoutová; Jolana Bártová; Ilja Tachecí; Stanislav Rejchrt; Rudolf Repák; Marcela Kopáčová; Jan Bureš
Journal:  Gastroenterol Res Pract       Date:  2013-11-24       Impact factor: 2.260

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.